Abstract:In our continuous effort to develop novel antiepileptic drug, a new series of nipecotic acid derivatives having1,3,4-thiadiazole nucleus were designed and synthesized. This study aims to improve the lipophilicity of nipecotic acid by attaching some lipophilic anchors like thiadiazole and substituted aryl acid derivatives. In our previous study, we noticed that the N-substituted oxadiazole derivative of nipecotic acid exhibited significant antiepileptic activity in the rodent model. The synthesized compounds were characterized by FT-IR, 1 H-NMR, 13 C-NMR, Mass, and elemental analysis. The anticonvulsant activity was evaluated by using the maximal electroshock-induced seizure model in rats (MES) and the subcutaneous pentylenetetrazol (scPTZ) test in mice. None of the compounds were found to be active in the MES model whereas compounds ( TN2, TN9, TN12, TN13, and TN15 ) produced significant protection against the scPTZ-induced seizures model. The compounds showing antiepileptic activity were additionally evaluated for antidepressant activity by using the forced swim test, 5-hydroxytryptophan (5-HTP)-induced head twitch test, and learned helplessness test. All the molecules that showed anticonvulsant activity ( TN2, TN9, TN12, TN13, and TN15 ), also exerted significant antidepressant effects in the animal models. The selected compounds were subjected to different toxicity studies. Compounds were found to have no neurotoxicity in the rota-rod test and devoid of hepatic and renal toxicity in 30 days repeated oral toxicity test. Further, a homology model was developed to perform the in-silico molecular docking and dynamics studies which revealed the similar binding of compound TN9 within the active binding pocket and were found to be the most potent anti-epileptic agent. The market expectation for newly developed antiepileptic thiadiazole-based nipecotic acid derivatives is significant, driven by their potential to offer improved therapeutic outcomes and reduced side effects, addressing a critical need in epilepsy treatment. These innovative compounds hold promise for meeting the demand for more effective and safer antiepileptic medications.

Progress in the Synthesis and Application of Nipecotic Acid and Its Derivatives

Application of Cinnamic Acid in the Structural Modification of Natural Products: A Review

Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide

Research progress in nicotinic acid receptor GPR109a and related agonists

Design, synthesis, molecular docking and pharmacological evaluation of some thiadiazole based nipecotic acid derivatives as a potential anticonvulsant and antidepressant agents

Recent progress in the synthesis of γ - Aminobutyric acid analogues

[Chemical and pharmacological progress on usnic acid and its derivatives].

α-Amino acid N-thiocarboxyanhydrides: A novel synthetic approach toward poly(α-amino acid)s

Medicinal chemistry of anthranilic acid derivatives: A mini review

Technology and functional insights into the nicotinamide mononucleotide for human health

Synthesis and Pesticidal Activity of New Niacinamide Derivatives Containing a Flexible, Chiral Chain

Progress on the synthesis of β-amino nitriles

Recent Research Advancements on Regioselective Nitrilase: Fundamental and Applicative Aspects

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide

Research Progress on the Synthesis of Δ1-Pipecolic Acid (P2C) and Its Derivatives

Recent Advances in the Biological Significance of Xanthine and its Derivatives: A Review

Backbone N-methylation of peptides: Advances in synthesis and applications in pharmaceutical drug development

Synthesis and modification of noscapine derivatives as promising future anticancer agents

Bioactivities and Structure-Activity Relationships of Usnic Acid Derivatives: A Review

Polyamine-containing natural products: structure, bioactivity, and biosynthesis